Cargando…
Fluorescent liposomal nanocarriers for targeted drug delivery in ischemic stroke therapy
Ischemic stroke causes acute CNS injury and long-term disability, with limited treatment options such as surgical clot removal or clot-busting drugs. Neuroprotective therapies are needed to protect vulnerable brain regions. The purinergic receptor P2X4 is activated during stroke and exacerbates post...
Autores principales: | Arul, Michael R., Alahmadi, Ibtihal, Turro, Daylin Gamiotea, Ruikar, Aditya, Abdulmalik, Sama, Williams, Justin T., Sanganahalli, Basavaraju G., Liang, Bruce T., Verma, Rajkumar, Kumbar, Sangamesh G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697427/ https://www.ncbi.nlm.nih.gov/pubmed/37902365 http://dx.doi.org/10.1039/d3bm00951c |
Ejemplares similares
-
Novel Injectable Fluorescent Polymeric Nanocarriers for Intervertebral Disc Application
por: Arul, Michael R., et al.
Publicado: (2023) -
Transcriptomic analysis reveals novel age-independent immunomodulatory proteins as a mode of cerebroprotection in P2X4R KO mice after ischemic stroke
por: Gamiotea-Turro, Daylin, et al.
Publicado: (2023) -
Design, Fabrication, and Validation of a Petri Dish-Compatible PDMS Bioreactor for the Tensile Stimulation and Characterization of Microtissues
por: Alhudaithy, Soliman, et al.
Publicado: (2020) -
Nanofiber matrix formulations for the delivery of Exendin-4 for tendon regeneration: In vitro and in vivo assessment
por: Abdulmalik, Sama, et al.
Publicado: (2023) -
Ligation Strategies for Targeting Liposomal Nanocarriers
por: Marqués-Gallego, Patricia, et al.
Publicado: (2014)